115 related articles for article (PubMed ID: 36250678)
1. Development and Validation of the VA Lung Cancer Mortality (VALCAN-M) Score for 90-Day Mortality Following Surgical Treatment of Clinical Stage I Lung Cancer.
Heiden BT; Eaton DB; Brandt WS; Chang SH; Yan Y; Schoen MW; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
Ann Surg; 2023 Sep; 278(3):e634-e640. PubMed ID: 36250678
[TBL] [Abstract][Full Text] [Related]
2. Association Between Surgical Quality Metric Adherence and Overall Survival Among US Veterans With Early-Stage Non-Small Cell Lung Cancer.
Heiden BT; Eaton DB; Chang SH; Yan Y; Baumann AA; Schoen MW; Tohmasi S; Rossetti NE; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
JAMA Surg; 2023 Mar; 158(3):293-301. PubMed ID: 36652269
[TBL] [Abstract][Full Text] [Related]
3. A Risk Score to Assist Selecting Lobectomy Versus Sublobar Resection for Early Stage Non-Small Cell Lung Cancer.
Gulack BC; Yang CJ; Speicher PJ; Yerokun BA; Tong BC; Onaitis MW; D'Amico TA; Harpole DH; Hartwig MG; Berry MF
Ann Thorac Surg; 2016 Dec; 102(6):1814-1820. PubMed ID: 27592602
[TBL] [Abstract][Full Text] [Related]
4. Marginal pulmonary function should not preclude lobectomy in selected patients with non-small cell lung cancer.
Taylor MD; LaPar DJ; Isbell JM; Kozower BD; Lau CL; Jones DR
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):738-44; Discussion 744-6. PubMed ID: 24252944
[TBL] [Abstract][Full Text] [Related]
5. The impact of preoperative body mass index on respiratory complications after pneumonectomy for non-small-cell lung cancer. Results from a series of 154 consecutive standard pneumonectomies.
Petrella F; Radice D; Borri A; Galetta D; Gasparri R; Solli P; Veronesi G; Spaggiari L
Eur J Cardiothorac Surg; 2011 May; 39(5):738-44. PubMed ID: 20952203
[TBL] [Abstract][Full Text] [Related]
6. Stage I non-small-cell lung cancer: long-term results of lobectomy versus sublobar resection from the Polish National Lung Cancer Registry.
Dziedzic R; Zurek W; Marjanski T; Rudzinski P; Orlowski TM; Sawicka W; Marczyk M; Polanska J; Rzyman W
Eur J Cardiothorac Surg; 2017 Aug; 52(2):363-369. PubMed ID: 28402455
[TBL] [Abstract][Full Text] [Related]
7. Early discharge on postoperative day 1 following lobectomy for stage I non-small-cell lung cancer is safe in high-volume surgical centres: a national cancer database analysis.
Drawbert HE; Hey MT; Tarrazzi F; Block M; Razi SS
Eur J Cardiothorac Surg; 2022 May; 61(5):1022-1029. PubMed ID: 34849695
[TBL] [Abstract][Full Text] [Related]
8. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
[TBL] [Abstract][Full Text] [Related]
9. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
10. Impact of Surgeon Volume on Outcomes of Older Stage I Lung Cancer Patients Treated via Video-assisted Thoracoscopic Surgery.
Smith CB; Wolf A; Mhango G; Wisnivesky JP
Semin Thorac Cardiovasc Surg; 2017 Summer; 29(2):223-230. PubMed ID: 28823334
[TBL] [Abstract][Full Text] [Related]
11. The National Surgical Quality Improvement Program risk calculator does not adequately stratify risk for patients with clinical stage I non-small cell lung cancer.
Samson P; Robinson CG; Bradley J; Lee A; Broderick S; Kreisel D; Krupnick AS; Patterson GA; Puri V; Meyers BF; Crabtree T
J Thorac Cardiovasc Surg; 2016 Mar; 151(3):697-705.e1. PubMed ID: 26410001
[TBL] [Abstract][Full Text] [Related]
12. Impact of tumor size on outcomes after anatomic lung resection for stage 1A non-small cell lung cancer based on the current staging system.
Carr SR; Schuchert MJ; Pennathur A; Wilson DO; Siegfried JM; Luketich JD; Landreneau RJ
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):390-7. PubMed ID: 22169444
[TBL] [Abstract][Full Text] [Related]
13. Risk of mortality from cardiovascular and respiratory causes in patients with chronic obstructive pulmonary disease submitted to follow-up after lung resection for non-small cell lung cancer.
Volpino P; Cangemi R; Fiori E; Cangemi B; De Cesare A; Corsi N; Di Cello T; Cangemi V
J Cardiovasc Surg (Torino); 2007 Jun; 48(3):375-83. PubMed ID: 17505444
[TBL] [Abstract][Full Text] [Related]
14. Pneumonectomy for primary lung cancer: contemporary outcomes, risk factors and model validation.
Brunswicker A; Taylor M; Grant SW; Abah U; Smith M; Shackcloth M; Granato F; Shah R; Rammohan K;
Interact Cardiovasc Thorac Surg; 2022 Jun; 34(6):1054-1061. PubMed ID: 34871415
[TBL] [Abstract][Full Text] [Related]
15. Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Saji H; Okada M; Tsuboi M; Nakajima R; Suzuki K; Aokage K; Aoki T; Okami J; Yoshino I; Ito H; Okumura N; Yamaguchi M; Ikeda N; Wakabayashi M; Nakamura K; Fukuda H; Nakamura S; Mitsudomi T; Watanabe SI; Asamura H;
Lancet; 2022 Apr; 399(10335):1607-1617. PubMed ID: 35461558
[TBL] [Abstract][Full Text] [Related]
16. European risk models for morbidity (EuroLung1) and mortality (EuroLung2) to predict outcome following anatomic lung resections: an analysis from the European Society of Thoracic Surgeons database.
Brunelli A; Salati M; Rocco G; Varela G; Van Raemdonck D; Decaluwe H; Falcoz PE;
Eur J Cardiothorac Surg; 2017 Mar; 51(3):490-497. PubMed ID: 27744321
[TBL] [Abstract][Full Text] [Related]
17. Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer.
Heiden BT; Eaton DB; Engelhardt KE; Chang SH; Yan Y; Patel MR; Kreisel D; Nava RG; Meyers BF; Kozower BD; Puri V
JAMA Netw Open; 2021 May; 4(5):e2111613. PubMed ID: 34042991
[TBL] [Abstract][Full Text] [Related]
18. Preoperative Pulmonary Function Tests (PFTs) and Outcomes from Resected Early Stage Non-small Cell Lung Cancer (NSCLC).
Almquist D; Khanal N; Smith L; Ganti AK
Anticancer Res; 2018 May; 38(5):2903-2907. PubMed ID: 29715115
[TBL] [Abstract][Full Text] [Related]
19. Patterns of survival and recurrence after surgical treatment of early stage non-small cell lung carcinoma in the ACOSOG Z0030 (ALLIANCE) trial.
Su S; Scott WJ; Allen MS; Darling GE; Decker PA; McKenna RJ; Meyers BF
J Thorac Cardiovasc Surg; 2014 Feb; 147(2):747-52: Discussion 752-3. PubMed ID: 24290575
[TBL] [Abstract][Full Text] [Related]
20. Sleeve lobectomy for non-small cell lung cancer with N1 nodal disease does not compromise survival.
Berry MF; Worni M; Wang X; Harpole DH; D'Amico TA; Onaitis MW
Ann Thorac Surg; 2014 Jan; 97(1):230-5. PubMed ID: 24206972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
